ClinicalTrials.Veeva
Menu

Find clinical trials for Non-Hodgkin Lymphoma in Tampa, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Lymphoma
B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Follicular Lymphoma
B-Cell Chronic Lymphocytic Leukemia
Recurrence
Mantle-Cell Lymphoma

Non-Hodgkin Lymphoma trials near Tampa, FL, USA:

A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL)

The purpose of this study is to evaluate the safety, tolerability, and preliminary efficacy of CC-99282 alone and in combination with anti-lymphoma...

Active, not recruiting
Lymphoma, Non-Hodgkin
Drug: Obinutuzumab
Drug: CC-99282

Phase 1, Phase 2

Celgene
Celgene

Tampa, Florida, United States and 68 other locations

The main goal of this study is to show that people with certain immune problems (from Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-...

Enrolling
Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
Drug: Gamunex-C, 10% Injectable Solution

Phase 3

Grifols
Grifols

St. Petersburg, Florida, United States and 4 other locations

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (a white blood cell responsible for fighting infections). The purp-...

Enrolling
Non-Hodgkin Lymphoma
Drug: Cyclophosphamide
Drug: Doxorubicin Hydrochloride [HCl]

Phase 2

Genmab
Genmab

Tampa, Florida, United States and 76 other locations

Study J2N-MC-JZ01 (JZ01) is an individual-study appendix (ISA) under master protocol J2N-MC-JZNY, and represents participants from the completed orig...

Enrolling
Non-Hodgkin Lymphoma
Chronic Lymphocytic Leukemia
Drug: Pirtobrutinib

Phase 4

Lilly
Lilly

Sarasota, Florida, United States and 34 other locations

This is an open-label, multi-center Phase 1b clinical study of oral AS-1763 (docirbrutinib) in patients with CLL/SLL or B-cell NHL who have failed or...

Enrolling
Marginal Zone Lymphoma
Follicular Lymphoma
Drug: Docirbrutinib

Phase 1

Carna Biosciences

Tampa, Florida, United States and 13 other locations

a bifunctional cereblon-dependent ligand-directed degrader of B-cell lymphoma 6 (BCL6), as a single agent and in combination with anti-lymphoma...

Enrolling
Relapsed/Refractory Non-Hodgkin Lymphoma
Drug: Rituximab
Drug: Glofitamab/Obinutuzumab

Phase 1, Phase 2

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Tampa, Florida, United States and 64 other locations

pharmacokinetic, pharmacodynamic, and clinical activity of AZD0486, a CD19 x CD3 T-cell engaging bispecific antibody, in subjects with B-cell non...

Enrolling
B-cell Non Hodgkin Lymphoma
Follicular Lymphoma
Drug: AZD0486 IV

Phase 1

AstraZeneca
AstraZeneca

Tampa, Florida, United States and 28 other locations

This study will evaluate the safety, efficacy, and pharmacokinetics of mosunetuzumab or glofitamab in combination with CELMoDs (CC-220 and/or CC-9928...

Enrolling
Non-Hodgkin Lymphoma
Drug: Golcadomide
Drug: IV Glofitamab

Phase 1

Roche
Roche

Tampa, Florida, United States and 25 other locations

with polatuzumab vedotin in participants with diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), and mantle cell lymphoma...

Active, not recruiting
B-cell Non-Hodgkin Lymphoma
Drug: Polatuzumab vedotin
Drug: Tocilizumab

Phase 1, Phase 2

Roche
Roche

Tampa, Florida, United States and 28 other locations

This is a Phase 1/1b, nonrandomized, open-label, parallel assignment, dose-escalation, and dose-expansion study to evaluate the safety and clinical a...

Enrolling
Small Lymphocytic Lymphoma
Non-Hodgkin Lymphoma
Biological: Azer-cel
Drug: Fludarabine

Phase 1

Imugene

Tampa, Florida, United States and 22 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems